Non-Viral Drug Delivery Systems Market to Witness Promising Growth Opportunities by 2024-2035 Date of Publication: 30-05-2025 The report titled ‘Non-Viral Drug Delivery Systems Market’ delivers a structured overview of how the industry has progressed over the years, along with expectations for future movement between 2025 and 2035. This report evaluates changes in the market size and highlights important developments within the industry. It offers clarity on regional patterns, key segments, and broader structural shifts without relying on speculative forecasting. The global non-viral drug delivery systems market size is estimated to be $8.6 billion in 2025 and is projected to reach $20.4 billion by 2035. The market is anticipated to grow at a CAGR of 9.0%, during the forecast period till 2035.. These projections are supported by current and historical performance metrics, highlighting regional and segment-level shifts across the global landscape. The study also outlines some of the major challenges and approaches being used across industry to adapt to evolving market conditions. The market forecast section provides a grounded view of potential movements over time, based on verified data and observed patterns. Source of information: - https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html This report includes a complete segmentation of the Non-Viral Drug Delivery Systems Market. The segmentation is based on Distribution by Type of Biologic Delivered, Type of Vehicle Used, Target Therapeutic Area, Type of Payment Employed, Key Geographical Regions, Companies Profiled. Key Geographies • Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune, PCI Biotech In addition to a high-level overview, the report also discusses market share shifts across these regions and the economic performance within each geography. It presents reliable estimates of projected revenue and market contribution, maintaining a neutral stance on causal relationships or future assumptions. Emphasis is placed on identifying key structural elements influencing Non-Viral Drug Delivery Systems Market growth across different regional and application-based divisions. The report features a detailed assessment of leading market participants, highlighting companies such as Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune, PCI Biotech. These companies have been profiled based on product focus, regional activity, and general business operations. The section on top companies in Non-Viral Drug Delivery Systems Market also evaluates how these firms have positioned themselves in response to market shifts, and how their current portfolios align with observed demand. Additional insights include the review of pricing models, cost structures, and supply chain operations relevant to the Non-Viral Drug Delivery Systems Market. The report includes discussion on raw material access, cost flow, distribution patterns, and processing rates, offering a deeper look at how value is created and maintained across different stages of production and delivery. The study also references recent strategic activities such as acquisitions, product launches, and geographic expansions. These developments are discussed in the context of how they impact competitive intensity and operational shifts within the Non-Viral Drug Delivery Systems Market. The analysis remains factual, highlighting observed actions without assigning subjective or future-looking projections. Research Methodology The methodology for this report includes both primary and secondary data collection from credible industry sources. Analysts have compiled information from public filings, interviews, industry portals, and market databases to ensure a high standard of accuracy. This approach ensures that the data used in the Non-Viral Drug Delivery Systems Market analysis is robust and suitable for industry decision-making. For any questions or to request a customized version of this report, please connect with our team. We’re available to help tailor the study to your specific needs and areas of interest. About Roots Analysis Roots Analysis is a leading business research and consulting firm known for its top-notch competitive intelligence, market research, and tailored consulting services. They dive deep into industries such as pharmaceuticals, biotechnology, medical devices, semiconductors and electronics, chemicals and materials, and information and communication technology, delivering high-quality analysis and practical insights. By offering customized solutions like market landscape mapping, competitive benchmarking, and opportunity analysis, Roots Analysis helps clients navigate complex markets and unlock growth with clear, data-driven strategies.

Atopic Dermatitis Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035 The latest report entitled‘Atopic Dermatitis Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the Atopic Dermatitis Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the Atopic Dermatitis Industry: Geographical Overview: • The latest report broadly categorizes the Atopic Dermatitis Market into several geographical terrains, including AbbVie, Anacor Pharmaceuticals, Bayer, Eli Lily and Company, Encore Dermatology, Galderma Laboratories, Incyte, LEO Pharma, MedPointe Pharmaceutical, Novartis AG, Otsuka Pharmaceutical, Pfizer, Regeneron Pharmaceuticals, Sanofi. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key companies in theAtopic Dermatitis Market: AbbVie, Anacor Pharmaceuticals, Bayer, Eli Lily and Company, Encore Dermatology, Galderma Laboratories, Incyte, LEO Pharma, MedPointe Pharmaceutical, Novartis AG, Otsuka Pharmaceutical, Pfizer, Regeneron Pharmaceuticals, Sanofi. Additional parameters of the Atopic Dermatitis Market report: The latest research study endows the reader with a comprehensive analysis of the product types of the Atopic Dermatitis industry, categorizing the relevant information into the Distribution by Type of Drug, Route of Administration, Type of Distribution Channel, Geographical Regions, Leading Market Players, PowerPoint Presentation(Complimentary). The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Read More :- https://www.rootsanalysis.com/reports/atopic-dermatitis-market.html

Quantum computing Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035 Drug discovery has always been a time-consuming process. On an average, it takes 10-15 years and capital investments worth USD 4-10 billion to commercially launch a drug. The global quantum computing market size is estimated to grow from USD 0.39 billion in 2024 to USD 1.63 billion by 2035, representing a CAGR of 13.86% during the forecast period till 2035. It involves various processes such as target identification, validation, hit generation, hit to lead and lead optimization. The term quantum computing refers to the technology that uses laws of quantum mechanics to solve large and complex problems in a short span as compared to the computer aided drug discovery. During our research, we were able to identify the presence of about 50 software providers that are engaged in offering services across drug discovery. Majority of the quantum computing software providers (45%) engaged in this domain were established post-2016. This is indicative of the growing interest of stakeholders in this domain. Examples of recently established companies include (post-2019, in alphabetical order) Algorithmiq (2020), Kuano (2020), Polaris Quantum Biotech (2020), Qubit Pharmaceuticals (2020) and Qunova Computing (2021). Additionally, 16% companies have entered this domain before 2000, indicating that the market is driven by efforts of well-established players as well. Further, it was observed that majority of players offer platform / software (98%) as a business capability followed by Quantum as a Service (69%). In addition to this 10% of the players offer platform capabilities for Drug Discovery and Drug Design. Majority (86%) of the players offer target discovery / identification as a drug discovery service followed by lead optimization (63%); examples of players offering all types of drug discovery service(s) include (in alphabetic order) Allesh Biosciences Lab, Hafnium Labs, Profacgen, Qsimulate and Roviant Discovery. The current market landscape is dominated by the presence of small companies (67%). Notable examples include (in alphabetical order) Aliro Quantum, Aqemia, Cloud Pharmaceuticals, Hafnium Labs, Phoremost and Qulab. In addition, the maximum number (19) of players are located in the US, followed by UK (5). Further, within the Asia-Pacific region, India emerged as the leading country, with the presence of four companies, including (in alphabetical order) Allesh Biosciences Lab, QpiAI, Qulab and Xanadu. Further, quantum computing software providers, focuses on various therapeutic area(s) primarily includes oncological disorders (67%) followed by infectious diseases (62%). It is worth noting that Denovicon Therapeutics offers software focusing on all types of therapeutic area(s). To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com